The global antihypertensive drugs market is estimated to grow at 1.2% during the forecast period, to reach USD 30 billion. Hypertension is a lifelong disease, which means that a patient may require to take medications every day for the rest of his/her life. Thus, the demand for anti-hypertensive dugs is sustainable and will increase with the rapidly increasing aging population.
This report studies Antihypertensive Drugs in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production, import and export of Antihypertensive Drugs in North America, Japan, Europe, India, Southeast Asia and China, forecast to 2020, from 2015.
Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Calcium channel blockers (CCB)
ACE inhibitors (ACE-I)
Angiotensin II receptor antagonists (ARB)
Adrenergic receptor antagonists
Aldosterone receptor antagonists
Alpha-2 adrenergic receptor agonists
Split by manufacturers, this report focuses on the sales, price of each type, average price of Antihypertensive Drugs, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Shihuida Pharm (China)
Second Pharmaceutical (China)
Yangtze River Pharmaceutical(China)
Split by regions, this report focuses on the sales (consumption), production, import and export of Antihypertensive Drugs in North America, Japan, Europe, India and China, from 2011 to 2020 (forecast), covering
Split by applications, this report focuses on consumption and growth rate of @@@@ in major applications.
Split by applications, covering
With 136 pages, 168 charts and eight chapters, to display the market present situation and future, clearly and deeply.